WannaCry ransomware may be authored by hackers from Southern China — mediaWorld May 29, 8:58
Russia’s Eastern Military District receives new shipment of Terminator helicoptersMilitary & Defense May 29, 8:18
North Korea test fires another missileWorld May 29, 1:29
Russia’s Zvyagintsev wins Jury Prize at 70th Cannes Film Festival with his LovelessSociety & Culture May 28, 21:32
Three Russian tourists hurt is road accident with tourist minibus in TurkeySociety & Culture May 28, 18:58
Some 40,000 cyclists taking part in Moscow cycle paradeSociety & Culture May 28, 18:33
Corporation Irkut: MS-21 first flight performed in routine modeBusiness & Economy May 28, 16:54
Ukrainian military launch more than 180 shells, mines on Donetsk within one dayWorld May 28, 16:36
Minister: Russia may supply 1,000 MC-21 planes to 2037Business & Economy May 28, 14:42
MOSCOW, July 12. /TASS/ Scientists from the Siberian Federal University (SFU) and Krasnoyarsk Research Center have developed a technology to produce magnetic nanoparticles of ferrihydrite for medical applications, the SFU press service said.
The ferrihydrite is formed in the course of bacterial activity and located on the cellular surface as the aggregations of nanograins. The special features of these nanoparticles obtained via bacterial synthesis could be applied in medicine, e.g. for magneto-controlled address drug delivery when the medicinal agent is attached to the nanoparticle and then relocated to the treatment spot by the focused magnetic field.
"On the one hand, it is carrying magnetic properties which points the above-described nanoparticles as very perspective driven carriers. On the other hand, due to their biogenic nature, these nanoparticles are absolutely safe for the human body," said one of the project team members, Alexander Krasikov.
The scientists note that the address delivery leads to lowering the input drug dosage and minimization of side effects to the body if compared to the traditional ways of medication.